A fine tuning of the AMPK mediated control over cell metabolism and ROS equilibrium would thus open new avenues for medical interventions in order to prevent GVHD or to sustain CAR-T cell homeostatic expansion in vivo. This evidence concerns the gene PRKAA1 and graft versus host disease.